Limited or “SORKON” and its subsidiaries (“the company”) would like to clarify the operating results for Quarter 3/2017 as following: Revenue and Net Sales The company recorded its total revenue of Baht

, due to the following reasons as follows; 1. Total incomes of the Company increase to 167.24 million baht equal to 240.37% against to the same period of last year mainly due to: 1.1) Revenue from Sales

Baht 308.4 million in Q1 2021. Excluding gain (loss) on foreign exchange, net profit margin (%) improved from 5.5% in Q1 2021 to 6.0% in Q1 2022 due to the following reasons: http://www.aapico.com/ http

year recorded the net profit in the amount of 8,618 million baht, increasing 1,845 million baht or 21.41% because of the following; 1. In 2017, the Company recorded sales income in an amount of 31,724

holders Exclude Gain (Loss) on exchange rate and one-time expenses 420.6 590.7 -170.2 -28.8% Net profit (loss) attributable to equity holders Margin (%) Exclude Gain (Loss) on exchange rate and one-time

mainly by hotel business performance improvement and the gain from the sale of other long-term investment The Company reported 1Q18 revenue of THB 1,698 million, an increase of 12.5%, mainly driven by

. 7 2 ) million or (2 0 2 % ) as the following reasons: • Total income increased Baht 92.32 million or 6% from Baht 1,580.25 million in 2017 to Baht 1,672.58 million in 2 0 1 8 . The main increase was

with the same period of last year. The income statement in brief is presented as following: DOD BIOTECH PUBLIC COMPANY LIMITED เลขที ่111 หมู่ที ่2 ต ำบลท่ำจีน อ ำเภอเมืองสมุทรสำคร จังหวดัสมุทรสำคร 74000

year increased by Baht 622 million as compared to last year and this was mainly due to the following:  The overall revenue from hotel operations which comprise of hotel, golf and retail operations

following reasons; - Sales increased by 649.52 million baht or 13.56 % from 4,790.47 million baht in 2018 to 5,439.99 million baht in 2019 due to the transfer of new 3 completed projects, Maestro19 Ratchada19